Non-vitamin K antagonist oral anticoagulant discontinuation in non-valvular atrial fibrillation patients (ASPECT-NOAC)

Basit Öğe Kaydı
dc.authorid0000-0003-0705-5090
dc.contributor.authorAsilturk, E.
dc.contributor.authorTulmac, M.
dc.contributor.authorBadak, O.
dc.contributor.authorOnal, T.
dc.contributor.authorAras, D.
dc.contributor.authorAciksari, G.
dc.contributor.authorAlper, A. T.
dc.date.accessioned2025-05-10T19:27:39Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.description.sponsorshipPfizer
dc.description.sponsorshipType of funding sources: Private company. Main funding source(s): This study was funded by Pfizer.
dc.identifier.endpage576
dc.identifier.issn0195-668X
dc.identifier.issn1522-9645
dc.identifier.scopusqualityQ1
dc.identifier.startpage576
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7012
dc.identifier.volume42
dc.identifier.wosWOS:000720456900536
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofEuropean Heart Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleNon-vitamin K antagonist oral anticoagulant discontinuation in non-valvular atrial fibrillation patients (ASPECT-NOAC)
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu